
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 152096
[patent_doc_number] => 07678832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-16
[patent_title] => 'Bis(thio-hydrazide amide) formulation'
[patent_app_type] => utility
[patent_app_number] => 11/502590
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17461
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/678/07678832.pdf
[firstpage_image] =>[orig_patent_app_number] => 11502590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/502590 | Bis(thio-hydrazide amide) formulation | Aug 9, 2006 | Issued |
Array
(
[id] => 5609163
[patent_doc_number] => 20060270679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/500252
[patent_app_country] => US
[patent_app_date] => 2006-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15844
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11500252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/500252 | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | Aug 6, 2006 | Abandoned |
Array
(
[id] => 8305944
[patent_doc_number] => 08227476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-24
[patent_title] => 'Use of flibanserin in the treatment of obesity'
[patent_app_type] => utility
[patent_app_number] => 11/997567
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5883
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11997567
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997567 | Use of flibanserin in the treatment of obesity | Jul 30, 2006 | Issued |
Array
(
[id] => 5338062
[patent_doc_number] => 20090054526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'INHIBITORS OF ANOREXIC LIPID HYDROLYSIS FOR THE TREATMENT OF EATING DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/995401
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13538
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054526.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995401 | INHIBITORS OF ANOREXIC LIPID HYDROLYSIS FOR THE TREATMENT OF EATING DISORDERS | Jul 13, 2006 | Abandoned |
Array
(
[id] => 5660993
[patent_doc_number] => 20060251589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases'
[patent_app_type] => utility
[patent_app_number] => 11/485486
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3389
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251589.pdf
[firstpage_image] =>[orig_patent_app_number] => 11485486
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/485486 | Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases | Jul 12, 2006 | Abandoned |
Array
(
[id] => 5391114
[patent_doc_number] => 20090208427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Vanillin Acetals and Sensory Stimulant Composition Containing the Same'
[patent_app_type] => utility
[patent_app_number] => 11/988237
[patent_app_country] => US
[patent_app_date] => 2006-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8858
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208427.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988237
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988237 | Vanillin acetals | Jul 4, 2006 | Issued |
Array
(
[id] => 5404630
[patent_doc_number] => 20090239944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Novel Use of Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/922558
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6262
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239944.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922558
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922558 | Novel Use of Organic Compounds | Jun 22, 2006 | Abandoned |
Array
(
[id] => 5338027
[patent_doc_number] => 20090054491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => ' Use'
[patent_app_type] => utility
[patent_app_number] => 11/921951
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7337
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054491.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921951
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921951 | Use | Jun 18, 2006 | Abandoned |
Array
(
[id] => 5057627
[patent_doc_number] => 20070060549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'COMBINATION THERAPIES EMPLOYING ACE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DIABETIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/424069
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9651
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060549.pdf
[firstpage_image] =>[orig_patent_app_number] => 11424069
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/424069 | COMBINATION THERAPIES EMPLOYING ACE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DIABETIC DISORDERS | Jun 13, 2006 | Abandoned |
Array
(
[id] => 5522084
[patent_doc_number] => 20090030065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Use of Pde1c and Inhibitors Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/921864
[patent_app_country] => US
[patent_app_date] => 2006-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6324
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030065.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921864 | Use of Pde1c and Inhibitors Thereof | Jun 12, 2006 | Abandoned |
Array
(
[id] => 6546230
[patent_doc_number] => 20100016346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'ELASMOBRANCH-REPELLING DOMPOUNDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/922065
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21909
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016346.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922065 | Elasmobranch-repelling compounds and methods of use | Jun 11, 2006 | Issued |
Array
(
[id] => 4873825
[patent_doc_number] => 20080200559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Substances Having Body Mass Redistribution Properties'
[patent_app_type] => utility
[patent_app_number] => 11/915838
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11244
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915838 | Substances having body mass redistribution properties | Jun 4, 2006 | Issued |
Array
(
[id] => 5204473
[patent_doc_number] => 20070025953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Co-therapy for diabetic conditions'
[patent_app_type] => utility
[patent_app_number] => 11/446053
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6529
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20070025953.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446053
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446053 | Co-therapy for diabetic conditions | Jun 1, 2006 | Abandoned |
Array
(
[id] => 5608101
[patent_doc_number] => 20060269617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Supplement compositions and method of use for enhancement of insulin sensitivity'
[patent_app_type] => utility
[patent_app_number] => 11/438204
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4490
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11438204
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/438204 | Supplement compositions and method of use for enhancement of insulin sensitivity | May 21, 2006 | Abandoned |
Array
(
[id] => 5270900
[patent_doc_number] => 20090074676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Inhibition of p38 MAPK For Treatment Of Obesity'
[patent_app_type] => utility
[patent_app_number] => 11/915008
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8195
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074676.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915008
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915008 | Inhibition of p38 MAPK For Treatment Of Obesity | May 21, 2006 | Abandoned |
Array
(
[id] => 4530971
[patent_doc_number] => 07887868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => 'Liquid seasoning'
[patent_app_type] => utility
[patent_app_number] => 11/436517
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6567
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/887/07887868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436517 | Liquid seasoning | May 18, 2006 | Issued |
Array
(
[id] => 5586082
[patent_doc_number] => 20090105284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/920038
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18667
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920038
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920038 | Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes | May 18, 2006 | Issued |
Array
(
[id] => 914553
[patent_doc_number] => 07326695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-05
[patent_title] => 'Anti-bacterial agents based upon oxoanion binding'
[patent_app_type] => utility
[patent_app_number] => 11/435978
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5565
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/326/07326695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11435978
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/435978 | Anti-bacterial agents based upon oxoanion binding | May 16, 2006 | Issued |
Array
(
[id] => 5338036
[patent_doc_number] => 20090054500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Composition and methods useful in preventing cardiac hypertrophy'
[patent_app_type] => utility
[patent_app_number] => 11/919846
[patent_app_country] => US
[patent_app_date] => 2006-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7254
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054500.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919846
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919846 | Composition and methods useful in preventing cardiac hypertrophy | May 11, 2006 | Abandoned |
Array
(
[id] => 5265621
[patent_doc_number] => 20090118306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Novel use of liver X receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/920141
[patent_app_country] => US
[patent_app_date] => 2006-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13032
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920141 | Use of liver X receptor agonists | May 9, 2006 | Issued |